Form 8-K PFIZER INC For: May 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pfizer (PFE) PT Lowered to $39 at Wolfe Research
June 1, 2020 8:36 AM EDTWolfe Research analyst Tim Anderson lowered the price target on Pfizer (NYSE: PFE) to $39.00 (from $41.00) while maintaining a Peerperform rating.
The analyst comments "We lower our peak estimate for Ibrance in 2027 (the year before patent loss) from $10.1B to $8.1B, with the decrement... More
Pfizer (PFE) PT Lowered to $36 at JPMorgan
June 1, 2020 7:41 AM EDTJPMorgan analyst Chris Schott lowered the price target on Pfizer (NYSE: PFE) to $36.00 (from $37.00) while maintaining a Neutral rating.
The analyst comments "We see a clear inflection in growth for Pfizer after the Lyrica patent expiration in 2019 with a reacceleration of the... More
